HONEYWELL AUTONOMYX
LIVE

Serial Number

99441721

Owner

Honeywell International Inc.

Attorney

Peter S. Sloane

Filing Date

Oct 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

HONEYWELL AUTONOMYX Trademark

Serial Number: 99441721

HONEYWELL AUTONOMYX is a trademark filed by Honeywell International Inc. on October 14, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Honeywell International Inc. (5 trademarks)

855 S. Mint St.

Entity Type: 03

Trademark Details

Filing Date

October 14, 2025

Registration Date

Not Registered

Published for Opposition

March 17, 2026

Goods & Services

Technological planning and consulting services in the field of cybersecurity, energy efficiency, decarbonization, industrial asset performance management, and predictive analytics, all for use in the oil and gas, chemicals, petrochemicals, mining, paper and pulp, power and utilities, steel, cement, renewable energy and sheet manufacturing industries

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 12, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2026 CNSA
ASSIGNED TO EXAMINER
Feb 23, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 14, 2025 MAFR
NEW APPLICATION ENTERED
Oct 14, 2025 NWAP

Related Trademarks

More in Same Class

HOMEAWAY

HOMEAWAY

MYPRO

MYPRO

THE LOCKWOOD GROUP

THE LOCKWOOD GROUP

SOFTWARE AS A SERVICE (SAAS) AND PLATFORM AS A SERVICE (PAAS) FEATURING ARTIFICIAL INTELLIGENCE SOFTWARE AND CLOUD-BASED PLATFORMS FOR USE IN MEDICAL DIAGNOSTICS, HEALTHCARE DATA ANALYSIS, DISEASE DETECTION, AND CLINICAL DECISION SUPPORT; PROVIDING TEMPORARY USE OF NON-DOWNLOADABLE SOFTWARE FOR ANALYZING GENOMIC, PROTEOMIC, METABOLOMIC, TRANSCRIPTOMIC, AND MULTI-OMICS DATA TO SUPPORT PRECISION MEDICINE AND PERSONALIZED HEALTHCARE; PROVIDING ONLINE NON-DOWNLOADABLE SOFTWARE USING MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE FOR BIOINFORMATICS, BIOLOGICAL DATA INTERPRETATION, BIOMARKER DISCOVERY, DRUG TARGET IDENTIFICATION, AND DRUG DISCOVERY; SCIENTIFIC AND TECHNOLOGICAL RESEARCH SERVICES IN THE FIELDS OF BIOTECHNOLOGY, LIFE SCIENCES, HEALTHCARE, AND ARTIFICIAL INTELLIGENCE, NAMELY, RESEARCH AND DEVELOPMENT OF DIAGNOSTIC METHODS, THERAPEUTIC STRATEGIES, AND BIOPHARMACEUTICAL TECHNOLOGIES; DESIGN, DEVELOPMENT, AND HOSTING OF CLOUD-BASED PLATFORMS FOR BIOMEDICAL DATA INTEGRATION, COMPUTATIONAL BIOLOGY, PREDICTIVE ANALYTICS, AND CLINICAL RESEARCH COLLABORATION.

SOFTWARE AS A SERVICE (SAAS) AND PLATFORM AS A SERVICE (PAAS) FEATURING ARTIFICIAL INTELLIGENCE SOFTWARE AND CLOUD-BASED PLATFORMS FOR USE IN MEDICAL DIAGNOSTICS, HEALTHCARE DATA ANALYSIS, DISEASE DETECTION, AND CLINICAL DECISION SUPPORT; PROVIDING TEMPORARY USE OF NON-DOWNLOADABLE SOFTWARE FOR ANALYZING GENOMIC, PROTEOMIC, METABOLOMIC, TRANSCRIPTOMIC, AND MULTI-OMICS DATA TO SUPPORT PRECISION MEDICINE AND PERSONALIZED HEALTHCARE; PROVIDING ONLINE NON-DOWNLOADABLE SOFTWARE USING MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE FOR BIOINFORMATICS, BIOLOGICAL DATA INTERPRETATION, BIOMARKER DISCOVERY, DRUG TARGET IDENTIFICATION, AND DRUG DISCOVERY; SCIENTIFIC AND TECHNOLOGICAL RESEARCH SERVICES IN THE FIELDS OF BIOTECHNOLOGY, LIFE SCIENCES, HEALTHCARE, AND ARTIFICIAL INTELLIGENCE, NAMELY, RESEARCH AND DEVELOPMENT OF DIAGNOSTIC METHODS, THERAPEUTIC STRATEGIES, AND BIOPHARMACEUTICAL TECHNOLOGIES; DESIGN, DEVELOPMENT, AND HOSTING OF CLOUD-BASED PLATFORMS FOR BIOMEDICAL DATA INTEGRATION, COMPUTATIONAL BIOLOGY, PREDICTIVE ANALYTICS, AND CLINICAL RESEARCH COLLABORATION.

QURII

QURII

AXIONYX

AXIONYX